Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like New portable biosensor could revolutionize heart failure screening at home August 19, 2024 Frequent musculoskeletal pain linked with increased risk of early retirement March 20, 2024 Study reveals coadministered COVID-19 and flu vaccines effective, especially in seniors November 13, 2023
Study reveals coadministered COVID-19 and flu vaccines effective, especially in seniors November 13, 2023